Maureen Hakske-Palomino, MSN, NP-BC

Center for Executive Medicine

6020 W PARKER RD STE 420


Clinical Pearls on the Management of Parkinson Disease

February 01, 2007

The ideal medication for Parkinson disease (PD) would reduce disability and halt or slow disease progression without intolerable adverse effects. Although such an agent is not yet available, current treatments offer significant symptom control for most patients. The decision about when to start therapy is highly individual; however, delaying treatment because of fear of adverse effects may not be in the patient's best interest.

Parkinson Disease: Essentials of Diagnosis

February 01, 2007

Parkinson disease (PD) is the second most common neurodegenerative disorder among elderly persons (after Alzheimer disease [AD]), and the incidence is expected to double in the next 15 to 20 years. About a million Americans have PD which means that it is about 3 times as common as multiple sclerosis and half as common as epilepsy.